Dr Reddy’s Laboratories is set to expand the capacity of three of its bulk drugs and intermediates manufacturing plants located in Telangana, with a combined investment of Rs 820 million. The company has applied for necessary approvals. It has proposed for expansion of bulk drugs and intermediates manufacturing unit (from 21.9 TPM to 68.76 TPM) in Medak district in Telangana. The company has allocated around Rs. 10,000 million towards expansion programme.
Company Profile : Dr Reddys Laboratories Ltd
Leave a Reply